Neurological presentation of intravascular lymphoma: report of two cases and discussion of diagnostic challenges
Eur J Neurol 12:710-714, Lozsadi, D.A.,et al, 2005
Ischemic Stroke as First Manifestation of Essential Thrombocythemia, Report of Six Cases
Stroke 26:1463-1466, Arboix,A.,et al, 1995
Idiopathic Thrombocytosis
Neurol 18:711-713, Levine,J.,et al, 1968
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Cerebrovascular Ischemia Associated with Lupus Anticoagulant
Stroke 18:257-263, Levine,S.R.&Welch,K.M.A., 1987
Episodic Neurologic Dysfunction in Patients with Hodgkin's Disease
Arch Neurol 43:1227-1233, Feldman,E.&Posner,J.B., 1986
Neurologic Manifestations of Essential Thrombocythemia
Ann Int Med 99:513-518, Jabaily,J.,et al, 1983
Case Record of MGH-NEJM Subdural Hematoma Secondary to Metastasis & Lacunar Infarcts
286:650, , 1972
Neurologic Complications of Polycythemia
Ann Int Med 57:909, Silverstein,A.,et al, 1962
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Pathophysiology of Thrombotic Thrombocytopenic Purpura
Int J Hematol 91:1-30, Tsai, H.M., 2010
Basilar Artery Embolism, Clin Synd & Neuroradiologic Patterns in Pts Without Perm Occl of Basilar Artery
Neurol 49:1346-1352, Schwarz,S.,et al, 1997
Cerebrovascular complic of Neurocysticercosis, Clin & Neuroimaging Spectrum
Arch Neurol 53:233-239, Cantu,C.&Barinagarrementeria,F., 1996
Lipids and Stroke
Arch Neurol 53:303-308, Hachinski,V.,et al, 1996
Recurrent Stroke and Thrombo-Occlusive Events in the Antiphospholipid Syndrome
Ann Neurol 38:119-124, Levine,S.R.,et al, 1995
Transient Neurologic and Ocular Manifestations in Primary Thrombocythemia
Neurol 43:1107-1110, Michiels,J.J.,et al, 1993
Intracranial Tumours that Mimic Transient Cerebral Ischaemia:Lessons from a Large Multicentre Trial
The UK TIA Study Group, JNNP 56:563-5661993., , 1993
Transient Ischemic Cerebral Lesions During Induction Chemotherapy for Acute Lymphoblastic Leukemia
J Pediatr 123:718-724, Pihko,H.,et al, 1993
Cerebrovascular and Neurologic Disease Associated with Antiphospholipid Antibodies:48 Cases
Neurol 40:1181-1189, Levine,S.R.,et al, 1990
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Neurologic Disease in Biopsy-Proven Giant Cell (Temporal) Arteritis
Neurol 38:352-359, Caselli,R.J.,et al, 1988
The Clinical Neuro-Ophthalmologic Spectrum of Temporal Arteritis
Am J Med 85:839-844, Mehler,M.F.&Rabinowich,L., 1988
Cerebral Infarct, TIA, & Lupus Inhibitor
Neurol 36:1234-1237, Fisher,M.&McGehee,W., 1986
Transient Tumor Attacks
Arch Neurol 40:633-636, Ross,R.T., 1983
Neurologic Aspects of Hereditary Hemorrhagic Telangiectasia
Arch Neurol 34:101, Adams,H.P.,et al, 1977
Cardiac Myxoma:A Diagnostic Challenge for the Neurologist
Neurol 26:1060, Yufe,R.,et al, 1976
Neurologic Manifest. of Infective Endocarditis:A Review
Stroke 4:958, Greenlee,J.E.,et al, 1973
Case Record of MGH-NEJM Atheromatous Emboli to Brain
Kidney, 286:11461972., , 1972
Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting:A Scientific Statement From the American HEart Association
Stroke 54:e109-e121, Hardik,P.A.,et al, 2023
Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack
Ann Neurol 91:380-388, Wang, A.,et al, 2022
Clinicopathological Conference, Systemic Lupus Erythematosus with Antiphospholipid Syndrome
NEJM 386:1560-1570, Case 12-2022, 2022
Cerebrovascular Ischemic Events in Patients with Takayasu Arteritis
Stroke 53:1550-1557, Mirouse, A.,et al, 2022
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
NEJM 382:9-19,81, Amarenco, P.,et al, 2020
Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke
Ann Neurol 88:946-955, Triantafyllou, S.,et al, 2020
Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
BMJ 360:k1717, Adderley, N.J.,et al, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
NEJM 379:215-225, 291, Johnston, S.C.,et al, 2018
Diagnostic Challenges in a Young Patient with Hypereosinophilia
Neurol 89:e159-e165, Ortiz, J.G.,et al, 2017
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
NEJM 374: DOI:10.1056/NEJMoa1506930, Kernan, W.N.,et al, 2016
Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016
Effects of Aspiring on Risk and Severity of Early Recurrent Stroke After Transient Ischaemic Attack and Ischaemic Stroke: Time-Course Analysis of Randomised Trials
Lancet: 388:365-375, 312, Rothwell, P.M.,et al, 2016
Outcomes with Edoxaban Versus Warfarin in Patients with Previous Cerebrovascular Events
Stroke 47:2075-2082, Rost, N.S.,et al, 2016
Effect of Clopidogrel with Aspirin on Functional Outcome in TIA or Minor Stroke
Neurol 85:573-579,562, Wang, X.,et al, 2015
Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack
Stroke 45:2160-2236, Kernan, W.N.,et al, 2014
Cryptogenic Stroke and Underlying Atrial Fibrillation
NEJM 370:2478-2486,2532, Sanna, T.,et al, 2014
Atrial Fibrillation in Patients with Cryptogenic Stroke
NEJM 370:2467-2477,2532, Gladstone, D.J.,et al, 2014
Pilot Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke
Stroke 44:528-530, Kamel, H.,et al, 2013
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
NEJM 369:11-19,82, Wang, Y.,et al, 2013